Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2010

Intravitreal Clindamycin and Dexamethasone for Zone 1 Toxoplasmic Retinochoroiditis at 24 Months

R. A. Garcia-Amaris; J. F. Arevalo; A. F. Lasave; M. Diaz-Llopis; C. Muccioli; R. Belfort, Jr.

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5884.

ARVO Annual Meeting Abstract May 2008

Intravitreal Bevacizumab (Avastin) for the Management of Refractory Pseudophakic Cystoid Macular Edema: 6 Month Results of the Pan American Collaborative Retina Study (PACORES) Group

L. Wu; J. Arevalo; M. Maia; R. A. Garcia-Amaris; J. Roca; J. G. Sanchez; M. H. Berrocal; Pan American Collaborative Retina Study (PACORES)Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3274.

ARVO Annual Meeting Abstract May 2007

Primary Intravitreal Bevacizumab for the Management of Pseudophakic Cystoid Macular Edema: 6-Months Follow-Up

R. A. Garcia-Amaris; J. G. Sanchez; L. Wu; M. H. Berrocal; M. Maia; J. Arevalo

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4156.

ARVO Annual Meeting Abstract May 2007

Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: 6-Months Follow-Up

J. G. Sanchez; L. Wu; M. Maia; M. J. Saravia; C. F. Fernandez; T. Evans; R. A. Garcia-Amaris; J. Arevalo

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5039.

Advertisement